High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.
about
The Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and ProgressionAnimal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and InflameSimple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insightSusceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver DiseaseProgression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study.Translational approaches: from fatty liver to non-alcoholic steatohepatitis.Identification of 5' AMP-activated kinase as a target of reactive aldehydes during chronic ingestion of high concentrations of ethanol.Noninvasive in vivo magnetic resonance measures of glutathione synthesis in human and rat liver as an oxidative stress biomarkerEmodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats.High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes.Fructose toxicity: is the science ready for public health actions?Insulin concentration modulates hepatic lipid accumulation in mice in part via transcriptional regulation of fatty acid transport proteins.Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in miceRodent models for metabolic syndrome research.Hepatic inflammation and fibrosis: functional links and key pathways.Potential risk factors for nonalcoholic steatohepatitis related to pancreatic secretions following pancreaticoduodenectomy.Nonalcoholic Steatohepatitis: A Search for Factual Animal Models.Soybean Oil Is More Obesogenic and Diabetogenic than Coconut Oil and Fructose in Mouse: Potential Role for the Liver.Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA.Coenzyme Q metabolism is disturbed in high fat diet-induced non-alcoholic fatty liver disease in ratsNutrigenomics of hepatic steatosis in a feline model: effect of monosodium glutamate, fructose, and Trans-fat feedingEfficacy of Dietary Lipid Control in Healing High-Fat and High-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats.Activation of Kupffer Cells Is Associated with a Specific Dysbiosis Induced by Fructose or High Fat Diet in MiceEffect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds.Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease PathogenesisAn Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisAll bariatric surgeries are not created equal: insights from mechanistic comparisons.A novel mice model of metabolic syndrome: the high-fat-high-fructose diet-fed ICR miceTherapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.Absence of keratin 8 or 18 promotes antimitochondrial autoantibody formation in aging male miceDietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid poolsAngiotensin receptor blockade recovers hepatic UCP2 expression and aconitase and SDH activities and ameliorates hepatic oxidative damage in insulin resistant rats.Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver DiseaseModest fructose beverage intake causes liver injury and fat accumulation in marginal copper deficient rats.Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primatesTranscriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis.Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonanceDevelopment of a diet-induced murine model of diabetes featuring cardinal metabolic and pathophysiological abnormalities of type 2 diabetes.
P2860
Q26775025-4FA22629-B892-45E4-959C-2A4B898FC98DQ26775571-B692CA87-C2D7-4629-A42D-9484F856E0D8Q26864513-27EA1647-4FAB-4651-80F9-37510D623C60Q28551941-1D9DE5C6-6B2B-42A8-BD6C-4842A96A6A36Q30375693-844CB48D-53F9-4455-8D35-3FDE18457AA4Q33887008-7152DD61-C7B9-40AE-A770-790C48C64AFDQ33946524-946F380A-8DFE-41DF-B472-E7CE7D15DC8EQ33958697-428556CE-032E-49CE-82A7-3DE53CCE8426Q34075939-857C8EDA-A38F-499E-BC74-49C8580792DCQ34159942-84996702-581C-4323-BD31-D47C51EF6544Q34191208-430740F3-B290-46C7-8F63-A2969DF60AA8Q34212924-F06FDA0B-12EE-4796-BA99-4B4F34AAFEF6Q34276656-0C56623F-4B83-4AEC-953E-36A7E65B7FCAQ34321195-5E7F7B7A-E72F-4319-9619-7912E188C34FQ34397051-34FFBE10-49AC-4E30-AF42-002E6D61F9B8Q34479248-31B5F0CB-F737-4B15-BDBD-ADD9B9EE0CA4Q35213917-0B404AAD-0C36-4C40-AF43-CB243F8FA190Q35235978-7EE0D3CD-5509-49DB-A086-B22DFECF6330Q35612535-26A93667-54AE-4080-AA05-78FDC0FBDDB7Q35705414-EDCE0EA1-406F-4252-9236-CF14ECF6AFFFQ35753377-F8234FD8-18AD-4D5C-9320-B821B5E28314Q35795775-CD24EE6D-2472-4383-8FB3-C5EF600AD8E8Q35863375-644342B9-DDDB-49BF-9670-E10C1062FD7EQ35884061-40A9B06D-0D16-4D89-AD58-39F8628B5D7FQ35885676-FA2E1CA9-83B7-49DF-B898-93A0482B23D2Q35903361-0EC2A057-BA5D-4140-8855-0DE8888FCF55Q35928542-AAB71A92-3E2C-45FA-872A-D057186926B1Q36071135-82DB5AD5-B254-44FD-BF2D-B30DCF2E965BQ36134542-F3F48F0D-913F-46E1-9FD7-98480DC23751Q36260840-016157DE-7494-41F9-BB49-2D9B55744FAEQ36295444-C1EE7071-33D3-4148-B475-1DC91538A1ACQ36299836-F8AFFC58-27FC-4A93-A674-7B09EED91CA2Q36322677-6AED9336-6017-44B1-8F05-62089E7A80B9Q36439575-8FEB8163-1C82-46D4-B8C0-641ECA56F788Q36818384-BC8569A1-3421-490D-AC2B-48DF1ABF4F68Q36961832-30122CD1-F512-475C-9049-1893F5174EF9Q37016475-68928C7E-EC34-448C-A930-67153151A00DQ37023975-0CB53A9C-5EC8-49A5-A661-92E25CE580BAQ37110696-1BAC7497-D6AE-478A-A17E-A278C1429890Q37216788-187305F9-75E6-4285-A8D0-A425963E5D2A
P2860
High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High-fructose, medium chain tr ...... nonalcoholic steatohepatitis.
@ast
High-fructose, medium chain tr ...... nonalcoholic steatohepatitis.
@en
High-fructose, medium chain tr ...... nonalcoholic steatohepatitis.
@nl
type
label
High-fructose, medium chain tr ...... nonalcoholic steatohepatitis.
@ast
High-fructose, medium chain tr ...... nonalcoholic steatohepatitis.
@en
High-fructose, medium chain tr ...... nonalcoholic steatohepatitis.
@nl
prefLabel
High-fructose, medium chain tr ...... nonalcoholic steatohepatitis.
@ast
High-fructose, medium chain tr ...... nonalcoholic steatohepatitis.
@en
High-fructose, medium chain tr ...... nonalcoholic steatohepatitis.
@nl
P2093
P2860
P50
P356
P1433
P1476
High-fructose, medium chain tr ...... nonalcoholic steatohepatitis.
@en
P2093
Ariel E Feldstein
Lili Miles
Michael V Miles
Michelle Kirby
Peter H Tang
Stavra A Xanthakos
Stephen C Woods
Vijay Saxena
William F Balistreri
P2860
P304
P356
10.1002/HEP.23797
P407
P577
2010-09-01T00:00:00Z